{"id":11176,"date":"2025-07-27T07:59:45","date_gmt":"2025-07-27T05:59:45","guid":{"rendered":"https:\/\/valintermed.com\/?p=11176"},"modified":"2025-07-27T07:59:45","modified_gmt":"2025-07-27T05:59:45","slug":"distrofiya-fuksa","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/fuksa-distrophy\/","title":{"rendered":"Fuchs' dystrophy"},"content":{"rendered":"
<\/div>\n

Fuchs' dystrophy (or partial corneal dystrophy) is a genetically determined disease characterized by degenerative changes in the cornea of the eye, which can lead to deterioration of visual function. The pathology under study is mainly manifested by changes in the cellular architecture and metabolism of the cornea, as well as frequent deposition of dystrophic complexes in the corneal stroma. The severity of symptoms may vary, but the most common manifestations are blurred vision, photophobia, and eye discomfort. It is important to note that this disease most often progresses with aging, although genetic factors play a critical role in its occurrence. <\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n